Company profile

TransAxon company profile

Current and currently planned BCIs are either very low resolution, unidirectional, or invasive - often all three. This greatly limits their therapeutic potential, let alone their use to enhance human capabilities or as an interface to simulated realities. TransAxon Ltd will revolutionise human use of computation, communications and AI through a technology pathway based on current and near-future neuro-engineering advances combined with deep learning algorithms. Our NZ-centred international team of experts in neuroscience and cognitive AI will solve the big problem of highly-augmentative BCIs, rapidly surpassing other nearer-term and less ambitious technologies and products.

Business identity

Contact email
[email protected]
Operating status
Active
Company type
For Profit
Employee range
00001-00010 employees
Founded
2021-08-30

Headquarters

Headquarters
Sandnes, Rogaland, Norway
Postal code
1052
Country code
NO
Continent
Europe

Capital profile

Funding and company signals

Funding stage
Seed
Funding rounds
2
Last funding
Grant / $12.2K / 2023-09-05
Last equity funding
Seed
Investors
2
Lead investors
1
Founders
2

Founders and investors

Founders

Michael WitbrockYunli Lu

Lead investors

Callaghan Innovation

Investors

Callaghan InnovationOutset Ventures

People at this company

Preview only. Contact details are available after you sign in.

Log in to view people and contact details at this company

Contact information and company affiliations may no longer be accurate. Verify details before reaching out.

Shipment data

Explore detailed shipment data

Sign in to view shipment history, products, suppliers, and trade lanes for this company.

Log in to view shipment data

Shipment records and coverage can change as the dataset is updated.